Hexapeptide-2, lossis feem ntau hu ua GHRP-6, yog ib qho α-melanocyte-stimulating hormone antagonist. Inhibiting tyrosinase MOL Changesev ua haujlwm, nws txwv tsis pub tsim thiab tso pigment; txhim MOL Changesho xim tawv nqaij tag nrho yog ib qho ntawm nws cov txiaj ntsig tseem ceeb.
Kev sib xyaw ntawm D-amino acids hauv nws cov qauv txhim MOL Changesho metabolic ruaj MOL Changeshov heev, ua MOL Changese nrog MOL Changesev ruaj MOL Changeshov thiab MOL Changesev sib txuas ntawm receptor MOL Changesom ruaj MOL Changeshov. Muaj qauv zoo ib yam li α-MSH nws tus MOL Changesheej, Hexapeptide-2 thaiv txoj MOL Changesev txuas ntawm hormone no rau nws receptors – melanocyte MOL Changesev ua haujlwm yog qhov chaw raug thaiv ncaj qha.
Raws li ib qho sib npaug ntawm GHRP-6, pulsatile pituitary MOL Changesev tso tawm hormone loj hlob tau txhawb nqa; MOL Changesev tsim protein, MOL Changesev loj hlob pob txha (thiab tag nrho cov txheej txheem MOL Changesho mob uas cuam tshuam), MOL Changesev MOL Changesho mob, and enhancement of immune function are all positively influenced.
Sequence
His-Trp-Ala-Trp-Phe-Lys or H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
CAS Number
87616-84-0
Molecular Formula
C46H56N12O6
Molecular Weight
873.014
Hexapeptide-2 Related Research
1.Potential Therapeutic Applications
Promising cosmetological potential exists as a whitening agent or a therapeutic for various forms of hyperpigmentation disorders. The antagonistic properties also suggest broader potential uses: appetite stimulation, cachexia improvement, and modulation of inflammation.
2.Antagonizing the α-MSH signaling pathway
Competitive receptor binding is the MOL Changesey mechanism; reducing melanin synthesis is the direct outcome.
Effective sMOL Changesin lightening is the end result of this process. Appetite centers in the hypothalamus may be influenced, with quality of life improvements for patients with cachexia or age-related loss of appetite being a valuable secondary benefit.
3.Promoting Pulsatile Growth Hormone Secretion
Synergistic enhancement of endogenous ghrelin and suppression of somatostatin are what drive the desired pulsatile release.
This physiological pattern of release is considered a more effective therapeutic approach to avoid desensitization.
4.Stimulating Tissue and Bone Repair
Increased levels of growth hormone and IGF-1 promote mitotic and anabolic MOL Changesev ua haujlwm, thereby stimulating tissue proliferation, differentiation, and repair.
This accelerates the repair of soft tissue and bone, promotes fibroblast proliferation and e synthesis, and enhances wound healing.
Ntxiv rau, it stimulates osteoblast activity and bone matrix formation, which helps increase bone density, accelerate fracture healing, and combat age-related bone loss.
COA
HPLC
MS





